The takeaway
Optimi Health Corp. Common Shares shows a pronounced seasonal pattern over 5 years of data — strongest in April (+3.7%) and softest in February (−11.4%).
Right now
In July, the stock has fallen 20% of years, averaging −2.2%, roughly 4.4 pts behind the S&P 500.
The full picture
Optimi Health Corp. Common Shares's most dependable month has been April, higher in 3 of 5 years; February has been its least reliable, up just 0% of the time.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Win rate % | ||||||||||||
| Median return % | ||||||||||||
| 2025 | ||||||||||||
| 2024 | ||||||||||||
| 2023 | ||||||||||||
| 2022 | ||||||||||||
| 2021 | — | — | — |
Month by month
The stock's clearest edge over the S&P 500 lands in May (+10.2 pts); it has trailed the market most in June (−14.9 pts).
“vs S&P” is Optimi Health Corp. Common Shares’s average for a month minus the S&P 500’s average for that same month — isolating Optimi Health Corp. Common Shares’s own seasonal edge from broad market drift.
Reality check
Over the last 5 years, April has closed higher 60% of the time versus 60% across the last 5 years — the pattern is holding.
Figures are the typical (median) April return and how often it rose — the last 5 years versus the last 5(the heatmap’s default window). This verdict stays anchored to that 5-year window even if you zoom the chart, so it never disagrees with the badges above.
In plain English
April looks the standout, up in 3 of 5 Aprils — yet the appeal is lumpy, leaning on the occasional blow-out year rather than dependable strength.
The headline flatters a touch — its +3.7% average sits well above the +1.9% a typical year delivers, the work of a few big Aprils. That reliability comes with real swings, mind — even April ranges by 14.1% from year to year, so any single year can land far from the average. Crucially, the gain is the stock's own rather than a rising tide's: April has cleared the S&P 500 by +2.1 points above the index.
Only November comes anywhere near it for reliability. At the other end of the calendar, February has been the soft spot — the weakest of 8 months that average a loss (−11.4%), and the edge isn't year-round — the stock has trailed the S&P 500 in June, February, and January. Its roughest month on record was a −39.7% June in 2022 — a reminder of how hard even a seasonal name can fall.
Hold it loosely, then: the April tendency is genuine but lumpy, more about the occasional outsized year than a gain to bank on. With a short 5-year record and returns that swing hard year to year, the signal is best held loosely.
Short answers on the stock's best month (April), its worst (February), and whether it really trades seasonally.
Yes, to a pronounced degree. Since 2021 its best month (April, +3.7%) has run well ahead of its worst (February, −11.4%) — the heatmap above shows how steady that gap has been year to year.
April has been the strongest, averaging +3.7% and closing higher in 3 of 5 years since 2021.
It's the weakest, averaging −11.4% — historically a soft spot, though it still varies from year to year.
Explore
These names have the strongest July track records on record — a starting point for comparison.
Before you trade